Amid the global COVID-19 pandemic that overwhelmed hospitals, upended the economy, and sent much of the world into lockdown, researchers tracked a concerning uptick in alcohol use.
Data for this study were sourced from a study collected between 2017 and 2019 among adolescents in grades 8, 10, and 12.
There was more than a threefold increase in US deaths from alcoholic cirrhosis between 1999 and 2019.
Investigators evaluated data collected for a population-based study of nearly 1.5 million adults that was conducted at seven sites across Australia.
Past 30-day polysubstance use is reported by 32.6 percent of adults who seek substance use treatment in the United States.
The study authors performed a structured equation modeling (SEM) protocol to build a theoretical model in which variables regarding sleep, mental health, and socioeconomic factors could be evaluated for their simultaneous effect on substance use.
Investigators sought to determine whether greater insomnia symptom severity predicted future alcohol use patterns during the COVID-19 pandemic.
Receipt of medical addiction therapy for alcohol use disorder is associated with a reduced incidence of alcohol-associated liver disease.
For this study, participants were recruited for a double-blind, randomized controlled treatment for alcohol use disorder.
From 1999 to 2019, opioid only and opioid/polysubstance-related mortality rates increased among the American Indian/Alaska Native (AI/AN) population.
